Insulin should not be given to obese type 2 diabetics with insulin resistance according to Dr. Roger Unger, professor of internal medicine at Southwestern University in Dallas, Texas, USA, who has investigated diabetes, obesity and insulin resistance for more than 50 years.

Obese diabetics given 30 mg of phentermine lost an average of 11.6 pounds in six months versus 3.9 pounds for those given a placebo according to a 1977 study.

Type 2 diabetics who were injected once-a-week with with 2 mg of long-acting release Byetta lost an average of 8.4 pounds after 3.75 months (15 weeks) according to a recent study from researchers at Amylin Pharmaceuticals, the makers of the drug. Patients given a dose of 0.8 mg once a week or a placebo did not lose weight. The long-acting release formula is under development by Amylin Pharmaceuticals, Inc. in San Diego, California, USA.

Type 2 diabetics given Topamax CR (topiramate controlled-release) lost an average of 13.2 pounds after four months versus 5.5 pounds for those given a placebo according to a study from researchers at the Dallas Diabetes and Endocrine Center in Dallas, Texas, USA.

Eating whole-grain breakfast cereals lowers the risk of type 2 diabetes according to a study from researchers at Harvard Medical School in Boston, Massachusetts, USA. Those eating at least 7 servings of whole-grain cereal per week were 37 percent less likely to get type 2 diabetes during an average follow-up of 19 years.

Men whose waist is 38-inches or greater are five times more likely to have type 2 diabetes than men with a waist measuring 34-inches or less.

Low-carb diets do not increase the risk of diabetes, even in those eating diets high in animal protein and animal fat, according to a new study from researchers at Harvard School of Public Health and the Harvard Medical School in Boston, Massachusetts, USA and from the UCLA School of Public Health, at the University of California, Los Angeles in Los Angeles, California, USA.

Ninety percent of diabetics have a body mass index ( BMI ) greater than 23 according to a report from the Government Office for Science in England.

According to the Nurses Cohort Study from the US, female nurses who were overweight, that is had a body mass index (BMI) of 25 or more, increased the risk of type 2 diabetes 5-fold, while having a BMI of 35 or more, severe obesity, increased the risk 93-fold notes the report Storing Up Problems: The Medical Case for a Slimmer Nation by the Royal College of Physicians. They note that this could help to explain why poor people are more likely to be obese in developed countries.

Diabetics who are overweight or obese who intentionally lose weight reduce their risk of dying by 25 percent a review paper points out.

People who underwent weight loss surgery were 92 percent less likely to die from diabetes during an average follow-up of 7.1 years according to a study from researchers at the University of Utah School of Medicine in Salt Lake City, Utah, USA.

People who drink 1-2 cups of coffee per day are 53 percent less likely to develop diabetes according to a study from Greece.

In type 2 diabetics, a weight loss of one percent of body weight reduced total health care costs by an average of 3.6 percent or $256 per year and diabetes-related costs by 5.8 percent or $131 per year. This according to a study of data from a health maintenance organization (HMO) for the period from July 1, 1997 through October 31, 2005.

Obese type 2 diabetics given 96 mg of Topamax (topiramate) twice a day lost an average of 14.2 pounds or 6.6 percent of their body weight after one year according to a study from Göteborg University in Göteborg, Sweden.

Sleep apnea may increase the risk of diabetes 2-fold according to a new study from Sweden. Severely obese subjects who lost weight, but continued to have sleep apnea were twice as likely to develop diabetes, and 1.9 times as likely to develop elevated triglycerides than those who got rid of their sleep apnea.

A weight loss of 7 to 11 pounds in obese people reduces the incidence of type 2 diabetes by 40 to 60 percent according a review paper by obesity researcher Arnie Astrup.

Type 2 diabetics taking 96 mg of Topamax (topiramate) twice a day—192 mg total—lost an average of 6.6 percent of body weight after one year.

Obese people who are at high risk of diabetes, who lose just 7 to 11 pounds reduce their risk of developing diabetes by 40 to 60 percent according to obesity researcher Arnie Astrup.

Ex-heavy smokers are 42 percent more likely to be obese than those who have never smoked, and current light smokers are 54 percent less likely to be obese according to a study from Finland.

Type 2 diabetics taking the anti-diabetes drug Byetta (exenatide) lost an average of 6.6 pounds after six months and 11.7 pounds after a year-and-a-half according to a new study from Maryland.

Type 2 diabetics taking the anti-diabetes drug Byetta (exenatide) lost an average of 4.6 pounds after six months and 9.7 pounds after a year-and-a-half according to a new study from New Orleans.

Weight loss is dose-dependent with the anti-diabetes drug Byetta (exenatide). Type 2 diabetics taking 5 mcg (micrograms) twice a day lost an average of 3.1 pounds after six months compared to 4.8 pounds for those taking 10 mcg twice a day.

Type 2 diabetics taking metformin (Glucophage) and Topamax (topiramate) lost 4.5 to 6.5 percent of their body weight after one year compared to 1.7 percent for those taking only metformin (Glucophage) according to a large study from the Medical University in Graz, Austria.

Light to moderate drinking is associated with a 20 to 58 percent reduction in the risk of type 2 diabetes in women according to a study from researchers at the Royal Free and University College Medical School in London, England.

Weight gain increases the risk of developing type 2 diabetes, even in people who are thin, according to a new study from Harvard School of Public Health in Boston, Massachusetts.